ArticleiScience2026
Synergistic disruption of redox and energy homeostasis via high-entropy layered double hydroxide nanozymes for enhanced tumor therapy.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The efficacy of nanozyme catalytic therapy is often affected by the complexity of tumor microenvironment (TME), since tumors use energy metabolism to resist oxidative stress. Relying only on disrupting the redox balance is usually not enough to completely remove the tumor. To address this problem, a high-entropy engineering strategy was developed to build a Pt-LDH nanozyme, where Pt clusters are anchored onto a high-entropy layered double hydroxide (LDH) support. This design endows the Pt-LDH with glucose oxidase (GOx)-like activity, which directly consumes intratumoral glucose to cut off the energy supply, overcoming the limitation of insufficient endogenous oxidants and stimulated subsequent oxidative stress. By simultaneously disrupting the energy metabolism and homeostasis, the Pt-LDH nanozyme achieves a potent synergistic therapeutic effect. Both
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.